Improving Solubility of Poorly Soluble Abiraterone Acetate by Cocrystal Design Aided by In Silico Screening
- 4 June 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 20 (8), 5018-5030
- https://doi.org/10.1021/acs.cgd.0c00153
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- The Role of BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in Drug DevelopmentJournal of Pharmaceutical Sciences, 2013
- Solubility Advantage of Amorphous Drugs and Pharmaceutical CocrystalsCrystal Growth & Design, 2011
- Density functional theory with London dispersion correctionsWIREs Computational Molecular Science, 2011
- Vibrational Spectroscopic Studies of Cocrystals and Salts. 2. The Benzylamine−Benzoic Acid SystemCrystal Growth & Design, 2009
- Infrared SpectroscopyPublished by Wiley ,2005
- Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?Chemical Communications, 2004
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Completion and refinement of crystal structures withSIR92Journal of Applied Crystallography, 1993
- Indexing of powder diffraction patterns for low-symmetry lattices by the successive dichotomy methodJournal of Applied Crystallography, 1991
- Encoding and decoding hydrogen-bond patterns of organic compoundsAccounts of Chemical Research, 1990